Table 4.

Characteristics of birth-related outcome; namely gestation time, birth weight in relation to gestation time, Apgar score, and congenital malformations in the study group n = 31 (MS^* patients exposed to TFL^** >30 consecutive days when becoming/partner becoming pregnant and up to 2 years after discontinuation of TFL treatment), and the reference group (n = 124).

	Study group (n = 31)		Reference group (n = 124)
	Male (n = 18)	Female (n = 13)	Male (n = 72)	Female (n = 52)
GESTATION TIME
Normal >37 weeks	17	2	67	34
Pre-term birth < 37 weeks	1	0	5	3
BIRTH WEIGHT IN RELATION TO GESTATIONAL WEEK
Normal	18	2	68	37
Low	0	0	3	0
APGAR SCORE
Low < 7	0	0	0	0
Normal ≥7	18	2	71 (1 missing)	37
CONGENITAL MALFORMATIONS
Plagiocephaly	1	0	1	0
Cardiac septum	0	0	1	0
Respiratory system	0	0	0	1

^*Multiple sclerosis.

^**Teriflunomide.